Advancing CNS Biotherapeutics and Crossing the Blood-Brain Barrier

일시 : 2019.01.14~15

장소 : San Diego, CA, United States of America

주관 : Cambridge Healthtech Institute

Cambridge Healthtech Institute’s 2nd Annual Advancing CNS Biotherapeutics and Crossing the Blood-Brain Barrier conference strives to bring you the hottest topics and biggest opportunities in discovery and development of highly efficacious therapeutic agents against CNS disorders and innovative strategies for delivering therapies across the blood-brain barrier (BBB). This conference will provide platform to brainstorm ideas and share new research on topics such as the biologics for CNS targets and biomarkers, brain cancer, neurodegeneration, neuroinflamation, neuroimmunology, alteration of CNS/BBB barriers due to injury or disease, preclinical models, neuroimaging, tools for prediction of brain penetration, and updates from the industry on topics such as antibody delivery and vector-mediated transport across BBB. This conference will feature stimulating discussions and a friendly place to network with peers. We invite you to present a poster, or to attend to learn from and network with the leading experts from around the globe.

2019 PIPELINES & AGENDAS

January 14-15
Recombinant Protein Therapeutics

January 15-16
Computational and Analytical Tools for Protein Engineering

January 17-18
Deep Sequencing and Single Cell Analysis for Antibody Discovery

January 14-15
Advancing CNS Biotherapeutics and Crossing the Blood-Brain Barrier

January 15-16
Next-Generation Approaches to Antibody Screening and Discovery

January 17-18
Deep Sequencing and Single Cell Analysis for Antibody Discovery

January 14-15
Engineering Next-Generation Cancer Immunotherapies

January 15-16
Antibody-Drug Conjugates

January 17-18
Bispecific Antibody Therapeutics

January 14-15
Optimizing Biologics Formulation Development

January 15-16
Lyophilization and Emerging Drying Technologies

January 17-18
Protein Aggregation and Emerging Analytical Tools

January 14-15
Characterization of Biotherapeutics

January 15-16
Detection and Characterization of Particulates and Impurities

January 17-18
Protein Aggregation and Emerging Analytical Tools

January 14-15
Bioprocess Data Management

January 15-16
Protein Purification and Recovery

January 17-18
Higher-Throughput Protein Production and Characterization

January 14-15
Engineering Genes, Vectors, Constructs, and Clones

January 15-16
Recombinant Protein Expression and Production

January 16-17
CHO Cell Lines

January 17-18
Optimizing Expression Platforms

January 14-15
Engineering Genes, Vectors, Constructs, and Clones

January 15-16
Advances in Vector Production and Scale-Up for Cell and Gene Therapy

January 17-18
Microbial Production